Skip to main content
. 2020 Dec 9;4(2):e1322. doi: 10.1002/cnr2.1322

TABLE 3.

Adverse events related with the EXTREME regimen

Any grade Grade 3/4
All Age < 70 Age ≥ 70 All Age < 70 Age ≥ 70
N = 86 N = 65 N = 21 P‐value N = 86 N = 65 N = 21 P‐value
Hematological
Leukopenia 61 (70.9%) 48 (73.8%) 13 (61.9%) .41 31 (36.0%) 25 (38.5%) 6 (28.6%) .45
Neutropenia 63 (73.3%) 49 (75.4%) 14 (66.7%) .57 36 (41.9%) 30 (46.2%) 6 (28.6%) .21
Anemia 74 (86.0%) 57 (87.7%) 17 (81.0%) .48 2 (2.3%) 2 (3.1%) 0 (0.0%) 1.00
Thrombocytopenia 47 (54.7%) 35 (53.8%) 12 (57.1%) 1.00 2 (2.3%) 1 (1.5%) 1 (4.8%) .43
Non‐hematological
Nausea 51 (59.3%) 44 (67.7%) 7 (33.3%) .01 7 (8.1%) 6 (9.2%) 1 (4.8%) 1.00
Vomiting 6 (7.0%) 6 (9.2%) 0 (0.0%) .33 0 (0.0%) 0 (0.0%) 0 (0.0%)
Anorexia 62 (72.1%) 46 (70.8%) 16 (76.2%) .78 6 (7.0%) 5 (7.7%) 1 (4.8%) 1.00
Diarrhea 16 (18.6%) 10 (15.4%) 6 (28.6%) .20 0 (0.0%) 0 (0.0%) 0 (0.0%)
Stomatitis 28 (32.6%) 20 (30.8%) 8 (38.1%) .60 0 (0.0%) 0 (0.0%) 0 (0.0%)
Rash acneiform 66 (76.7%) 49 (75.4%) 17 (81.0%) .77 4 (4.7%) 4 (6.2%) 0 (0.0%) .57
Febrile neutropenia 2 (2.3%) 1 (1.5%) 1 (4.8%) .43
Creatinine increased 12 (13.9%) 10 (15.4%) 2 (9.5%) .72 0 (0.0%) 0 (0.0%) 0 (0.0%)
Peripheral sensory neuropathy 25 (29.1%) 20 (30.8%) 5 (23.8%) .59 1 (1.2%) 1 (1.5%) 0 (0.0%) 1.00